Curis News

Curis, Inc. , a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that several abstracts on its partnered programs have been accepted by the American Society of Clinical Oncology for presentation at its 2012 Annual Meeting being held from June 1-5 in Chicago, ... (more)

HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia Curis, Inc.

Best strength from prior mentions;A A A A LUXR nicely bought into on midday decline.....debate for intraday volatility given... Magic Reports Strong Start to 2012 With Q1 Revenues of $30 Million and Net Income of $4.2 Million, an Increase of 35% Year Over Year InPlay: Curis announces collaborator Roche's submission of Erivedge for registration with ... (more)